BioReference and its subsidiary GenPath, together the third-largest clinical laboratory in the U.S., perform routine clinical chemistry testing and diagnostics for women’s health, anatomic pathology, and molecular testing for disease risk screening and tumor sequencing.
When the COVID-19 pandemic broke, BioReference had an opportunity to make a major impact, but they needed to scale quickly. With LEAP's support, the organization led the nation in laboratory turn-around-time and became the official testing lab for all national sports leagues, Disney campuses, and some of the largest municipalities and school systems in the country.
LEAP has supported BioReference's digital strategy, architecture, program management, and software needs to enable the organization to scale their clinical offerings and capabilities and maximize revenue.
Strategic advice to IT, Data Sciences, and Bioinformatics leadership teams on digital operations, enterprise architecture, and solution road mapping
Driving enterprise architecture and big-picture planning across client, clinical, lab, and revenue cycle
Led multiple cycles of organizational planning, process improvement, and platform modernization
New patient and provider digital experiences
New clinical and research diagnostics
New processes from patient experience through clinical workflow
Effective insurance reimbursement and patient billing
Migrated billing from mainframe to cloud and vendor platforms
Solution design and journey mapping
Business analysis
Project management
Cloud enterprise software development
Clinical data warehouse and genomics research data platform
.svg)
.svg)
